BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27891566)

  • 1. Sudden death associated with syndromic craniosynostosis.
    Ginelliová A; Farkaš D; Iannaccone SF; Vyhnálková V; Vasovčák P
    Forensic Sci Med Pathol; 2016 Dec; 12(4):506-509. PubMed ID: 27891566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further analysis of the Crouzon mouse: effects of the FGFR2(C342Y) mutation are cranial bone-dependent.
    Liu J; Nam HK; Wang E; Hatch NE
    Calcif Tissue Int; 2013 May; 92(5):451-66. PubMed ID: 23358860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
    Ang BU; Spivak RM; Nah HD; Kirschner RE
    J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal exclusion of Crouzon syndrome by mutation analysis of FGFR2.
    Phupong V; Srichomthong C; Shotelersuk V
    Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):977-9. PubMed ID: 15916101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The craniofacial phenotype of the Crouzon mouse: analysis of a model for syndromic craniosynostosis using three-dimensional MicroCT.
    Perlyn CA; DeLeon VB; Babbs C; Govier D; Burell L; Darvann T; Kreiborg S; Morriss-Kay G
    Cleft Palate Craniofac J; 2006 Nov; 43(6):740-8. PubMed ID: 17105336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early mandibular morphological differences in patients with FGFR2 and FGFR3-related syndromic craniosynostoses: A 3D comparative study.
    Morice A; Cornette R; Giudice A; Collet C; Paternoster G; Arnaud É; Galliani E; Picard A; Legeai-Mallet L; Khonsari RH
    Bone; 2020 Dec; 141():115600. PubMed ID: 32822871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of
    Lee KKL; Peskett E; Quinn CM; Aiello R; Adeeva L; Moulding DA; Stanier P; Pauws E
    Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30266836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe craniolacunae and upper and lower extremity anomalies resulting from Crouzon syndrome, FGFR2 mutation, and Ser347Cys variant.
    Raposo-Amaral CE; Oliveira YM; Denadai R; Raposo-Amaral CA; Ghizoni E
    Childs Nerv Syst; 2021 Jul; 37(7):2391-2397. PubMed ID: 33404724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S267P mutation in FGFR2: first report in a patient with Crouzon syndrome.
    Ke R; Yang X; Ge M; Cai T; Lei J; Mu X
    J Craniofac Surg; 2015 Mar; 26(2):592-4. PubMed ID: 25759927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype and clinical care correlations in craniosynostosis: findings from a cohort of 630 Australian and New Zealand patients.
    Roscioli T; Elakis G; Cox TC; Moon DJ; Venselaar H; Turner AM; Le T; Hackett E; Haan E; Colley A; Mowat D; Worgan L; Kirk EP; Sachdev R; Thompson E; Gabbett M; McGaughran J; Gibson K; Gattas M; Freckmann ML; Dixon J; Hoefsloot L; Field M; Hackett A; Kamien B; Edwards M; Adès LC; Collins FA; Wilson MJ; Savarirayan R; Tan TY; Amor DJ; McGillivray G; White SM; Glass IA; David DJ; Anderson PJ; Gianoutsos M; Buckley MF
    Am J Med Genet C Semin Med Genet; 2013 Nov; 163C(4):259-70. PubMed ID: 24127277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchondrosis fusion contributes to the progression of postnatal craniofacial dysmorphology in syndromic craniosynostosis.
    Hoshino Y; Takechi M; Moazen M; Steacy M; Koyabu D; Furutera T; Ninomiya Y; Nuri T; Pauws E; Iseki S
    J Anat; 2023 Mar; 242(3):387-401. PubMed ID: 36394990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicogenetic study of Turkish patients with syndromic craniosynostosis and literature review.
    Nur BG; Pehlivanoğlu S; Mıhçı E; Calışkan M; Demir D; Alper OM; Kayserili H; Lüleci G
    Pediatr Neurol; 2014 May; 50(5):482-90. PubMed ID: 24656465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extremely severe scoliosis, heterotopic ossification, and osteoarthritis in a three-generation family with Crouzon syndrome carrying a mutant c.799T>C FGFR2.
    Lin M; Lu Y; Sui Y; Zhao N; Jin Y; Yi D; Jiang M
    Mol Genet Genomic Med; 2019 Sep; 7(9):e843. PubMed ID: 31318164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ala344Pro mutation in the FGFR2 gene and related clinical findings in one Chinese family with Crouzon syndrome.
    Lin Y; Ai S; Chen C; Liu X; Luo L; Ye S; Liang X; Zhu Y; Yang H; Liu Y
    Mol Vis; 2012; 18():1278-82. PubMed ID: 22665975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minor Suture Fusion in Syndromic Craniosynostosis.
    Runyan CM; Xu M D W; Alperovich M; Massie M D JP; Paek G; Cohen BA; Staffenberg DA; Flores RL; Taylor JA
    Plast Reconstr Surg; 2017 Sep; 140(3):434e-445e. PubMed ID: 28574949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndromic Craniosynostosis.
    Wang JC; Nagy L; Demke JC
    Facial Plast Surg Clin North Am; 2016 Nov; 24(4):531-543. PubMed ID: 27712819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the effect of mutations of the fibroblast growth factor receptors as exemplified by three cases of craniosynostoses].
    Preising MN; Schindler S; Friedrich M; Wagener H; Golan I; Lorenz B
    Klin Monbl Augenheilkd; 2003 Oct; 220(10):669-81. PubMed ID: 14577033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Q289P mutation in the FGFR2 gene: first report in a patient with type 1 Pfeiffer syndrome.
    Piccione M; Antona V; Niceta M; Fabiano C; Martines M; Bianchi A; Corsello G
    Eur J Pediatr; 2009 Sep; 168(9):1135-9. PubMed ID: 19066959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis.
    Eswarakumar VP; Ozcan F; Lew ED; Bae JH; Tomé F; Booth CJ; Adams DJ; Lax I; Schlessinger J
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18603-8. PubMed ID: 17132737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant bony vasculature associated with activating fibroblast growth factor receptor mutations accompanying Crouzon syndrome.
    Tholpady SS; Abdelaal MM; Dufresne CR; Gampper TJ; Lin KY; Jane JA; Morgan RF; Ogle RC
    J Craniofac Surg; 2004 May; 15(3):431-5; discussion 436-8. PubMed ID: 15111803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.